Sri Trang Agro-Industry Public Company Limited (SGX:NC2)

Ligand Pharmaceuticals Ratios and Metrics

Market cap in millions SGD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 11, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	843	1,105	949	1,257	1,933	1,792
Market Cap Growth	-41.47%	16.43%	-24.47%	-34.98%	7.87%	158.19%
Enterprise Value	2,706	3,255	2,178	2,594	2,985	2,502
Last Close Price	0.51	0.62	0.54	0.69	0.98	0.80
PE Ratio	16.88	16.64	-	6.76	3.01	4.27
PS Ratio	0.17	0.24	0.29	0.29	0.40	0.54
PB Ratio	0.32	0.40	0.36	0.47	0.73	0.76
P/TBV Ratio	0.47	0.59	0.53	0.68	1.11	1.18
P/FCF Ratio	2.03	-	-	6.25	16.75	4.81
P/OCF Ratio	1.62	-	8.57	2.07	3.26	3.72
EV/Sales Ratio	0.52	0.72	0.67	0.60	0.62	0.75
EV/EBITDA Ratio	8.54	11.73	15.76	7.26	2.34	2.86
EV/EBIT Ratio	18.97	25.33	192.42	10.61	2.56	3.29
EV/FCF Ratio	6.53	-	-	12.91	25.87	6.72
Debt / Equity Ratio	0.51	0.78	0.55	0.59	0.64	0.60
Debt / EBITDA Ratio	4.44	7.48	9.80	4.31	1.31	1.61
Debt / FCF Ratio	3.30	-	-	7.83	14.56	3.81
Asset Turnover	1.14	0.94	0.74	0.96	1.14	1.00
Inventory Turnover	4.36	3.04	2.91	3.28	3.11	3.30
Quick Ratio	1.01	0.54	1.34	2.20	1.12	1.16
Current Ratio	2.56	1.62	3.28	4.09	2.20	1.77
Return on Equity (ROE)	2.62%	3.16%	-0.66%	8.22%	44.20%	39.03%
Return on Assets (ROA)	1.90%	1.66%	0.16%	3.40%	17.29%	14.26%
Return on Capital (ROIC)	2.01%	1.76%	0.17%	3.65%	18.70%	15.41%
Return on Capital Employed (ROCE)	3.80%	3.50%	0.30%	6.10%	34.30%	28.50%
Earnings Yield	5.92%	6.01%	-1.76%	14.79%	33.28%	23.42%
FCF Yield	49.15%	-50.99%	-9.93%	15.99%	5.97%	20.79%
Dividend Yield	7.62%	6.39%	7.17%	11.17%	17.17%	12.41%
Payout Ratio	120.59%	91.95%	-	52.86%	50.89%	13.69%
Buyback Yield / Dilution	-0.67%	-	-	-	-	-
Total Shareholder Return	6.94%	6.39%	7.17%	11.17%	17.17%	12.41%

Updated Feb 17, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.